Moneycontrol PRO
you are here: HomeNewsIndia

COVID-19 Vaccine Tracker: 42.67 lakh doses administered in India on July 23

The Centre told the Lok Sabha on the day that no fixed timeline can be indicated now for the completion of the COVID-19 vaccination drive in the country in view of the dynamic and evolving nature of the pandemic

July 24, 2021 / 09:45 AM IST
Healthcare workers carry Covishield vaccine, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, to inoculate villagers during a door-to-door vaccination and testing drive at Uttar Batora Island in Howrah district in West Bengal. (Representative image: Reuters)

Healthcare workers carry Covishield vaccine, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, to inoculate villagers during a door-to-door vaccination and testing drive at Uttar Batora Island in Howrah district in West Bengal. (Representative image: Reuters)

More than 42.67 lakh vaccine doses were administered in India on July 23, the Union Health Ministry's latest provisional report suggested. With that, the cumulative number of COVID-19 vaccine doses administered in the country crossed 42.78 crores.

On the 189th day of the vaccination drive on July 23, 27.25 lakh beneficiaries received their first shot and 15.42 lakh people were given their second dose.

The government has revised the gap between the two doses for the Oxford-AstraZeneca's Covishield, manufactured by the Serum Institute of India, to 12-16 weeks. However, the interval for the second dose of Bharat Biotech's Covaxin remains unchanged.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Prime Minister Narendra Modi launched the nationwide vaccination drive on January 16, with healthcare workers at the frontline of India's COVID-19 battle getting their first jabs. The country began the second phase of the vaccination drive from March 1, in which, everyone above 60 years of age and those over 45 years with comorbidities could start getting the vaccine.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

From April 1, vaccination was opened for everyone aged 45 and above with or without comorbidities.

India rolled out the third phase of its COVID-19 vaccination drive for those in the 18-44 age group on May 1.

The central government has 'liberalised' the vaccination drive to allow states, private hospitals, and industrial establishments to procure the doses directly from manufacturers. However, later it announced to provide free COVID-19 vaccines to everyone above the age of 18 years from June 21. The new COVID-19 vaccination policy is a significant shift from the government's 'liberalised and accelerated' policy, announced earlier.

Registration on CoWIN platform for the third phase began on April 28 and is mandatory for the 18-44 age group.

Here are key developments related to the COVID-19 vaccination process:

- More than 2.75 crore balance and unutilized COVID-19 vaccine doses are still available with the states, union territories and private hospitals to be administered, the Union Health Ministry said on July 23. Over 43.87 crore vaccine doses have been provided to states and UTs so far through all sources and a further 71,40,000 doses are in the pipeline, it said.

- The Centre told the Lok Sabha on the day that no fixed timeline can be indicated now for the completion of the COVID-19 vaccination drive in the country in view of the dynamic and evolving nature of the pandemic but it is expected all beneficiaries aged 18 years and above will be inoculated by December this year.

- The Tamil Nadu government said on the day that it would soon commence its free vaccination drive at private health care facilities that will receive funds for the vaccines from corporates under the CSR initiative. Those hospitals providing vaccines free of cost would place a board in front of their facility, informing the public of the initiative, to enable them receive the jabs, minister for medical and family welfare Ma Subramanian said after chairing a meeting with hospitals and corporates of Chennai and neighbouring districts.

- A team of central government officials is in continuous dialogue with foreign Covid vaccine manufactures like Pfizer, Moderna and Johnson and Johnson to discuss and address various issues, including indemnity, the Lok Sabha was informed on the day. Providing the present status of discussions with pharma companies like Pfizer and Moderna over giving them indemnity against cost of compensation for adverse effects due to vaccination, Union Minister Bharati Pravin Pawar in a written reply said the government constituted the team on June 11 to deal with various issues related to procurement of COVID-19 vaccine from foreign manufacturers.

Here's the vaccination count for some states:
StatesTotal Beneficiaries
Andhra Pradesh1,94,73,722
Arunachal Pradesh8,06,781
Assam95,34,775
Bihar 2,17,16,355
Chandigarh7,31,391
Chhattisgarh 1,13,52,836
Delhi96,03,697
Goa12,43,867
Gujarat 3,10,24,902
Haryana1,09,41,702
Himachal Pradesh48,41,257
Jharkhand 85,77,241
Karnataka2,85,59,712
Kerala 1,79,76,323
Madhya Pradesh2,68,59,290
Maharashtra4,08,56,283
Odisha1,52,44,784
Punjab91,04,405
Rajasthan 3,01,17,834
Tamil Nadu2,07,27,939
Telangana1,38,43,216
Uttar Pradesh4,38,13,753
Uttarakhand 54,98,610
West Bengal2,73,41,488

(With inputs from PTI)

Click here for Moneycontrol’s full coverage of the coronavirus pandemic
Moneycontrol News

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark